127 related articles for article (PubMed ID: 2972536)
21. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
[TBL] [Abstract][Full Text] [Related]
22. [The effect of lymphocytic chalone on lymphocyte functional activity in antioxidant deficiency and its correction with vitamin E].
Harkava KH; Afonina HB; Zadorina OV; Briuzhina TS
Fiziol Zh (1994); 1995; 41(5-6):27-32. PubMed ID: 9026388
[TBL] [Abstract][Full Text] [Related]
23. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA
Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450
[TBL] [Abstract][Full Text] [Related]
24. [A method of isolating inhibitors of the proliferative activity of liver hepatocytes].
Okulov VB; Chekulaeva LI
Arkh Anat Gistol Embriol; 1976 Jan; 70(1):106-9. PubMed ID: 130098
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871
[TBL] [Abstract][Full Text] [Related]
26. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo.
Liu CD; Kwan D; Saxton RE; McFadden DW
J Surg Res; 2000 Sep; 93(1):137-43. PubMed ID: 10945955
[TBL] [Abstract][Full Text] [Related]
27. Telomerase as a new target for pancreatic cancer treatment.
Sato N; Mizumoto K; Nagai E; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
[TBL] [Abstract][Full Text] [Related]
28. [Effect of an erythrocytic chalone on the postsynthetic period of the erythroblastic mitotic cell cycle in mouse bone marrow].
Neustroev GV
Arkh Anat Gistol Embriol; 1980 Jul; 79(7):69-73. PubMed ID: 6448032
[TBL] [Abstract][Full Text] [Related]
29. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
30. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
[TBL] [Abstract][Full Text] [Related]
31. Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1.
Ohta T; Arakawa H; Futagami F; Fushida S; Kitagawa H; Kayahara M; Nagakawa T; Miwa K; Kurashima K; Numata M; Kitamura Y; Terada T; Ohkuma S
J Pathol; 1998 Jul; 185(3):324-30. PubMed ID: 9771488
[TBL] [Abstract][Full Text] [Related]
32. [Action of a chalone-containing esophageal preparation on its epithelial cell proliferation].
Torshina IG; Romanov IuA
Biull Eksp Biol Med; 1986 Dec; 102(12):749-51. PubMed ID: 2948573
[TBL] [Abstract][Full Text] [Related]
33. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
34. Failure of tripeptide colon mitosis inhibitor to suppress the cell proliferation of dimethylhydrazine-induced colonic cancers in rats.
Pawlikowski M; Zerek-Mełeń G; Stepień H; Lachowicz A; Winczyk K; Szadowska A
Cytobios; 1993; 76(306-307):151-5. PubMed ID: 8181305
[TBL] [Abstract][Full Text] [Related]
35. Tributyrin, a butyrate precursor, impairs growth and induces apoptosis and differentiation in pancreatic cancer cells.
Gaschott T; Maassen CU; Stein J
Anticancer Res; 2001; 21(4A):2815-9. PubMed ID: 11724360
[TBL] [Abstract][Full Text] [Related]
36. The effect of liposome-entrapped specific cell growth inhibitor (chalone) on tumour cell proliferation.
Bogoeva MV; Gabev EE; Botev BA
J Microencapsul; 1988; 5(1):59-64. PubMed ID: 2974075
[TBL] [Abstract][Full Text] [Related]
37. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
Paulsen JE; Elgjo K
In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
[TBL] [Abstract][Full Text] [Related]
38. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.
Abe M; Yamashita J; Ogawa M
Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710
[TBL] [Abstract][Full Text] [Related]
39. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
40. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
